Company
Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Metagenomi

Main focus: Next-generation gene-editing systems

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas9, multiple undisclosed

Funding stage: Private

Location: Everyville, CA, USA

Website: https://metagenomi.co/

Partners: Moderna, Vor Biopharma

Metagenomi is a start-up gene-editing company that applies its proprietary metagenomics-powered discovery platform to discover and develop next-generation gene-editing systems. The company has yet not disclosed any of its lead programmes, but announced a multi-year, multi-target collaboration with Moderna to develop in vivo gene-editing therapeutics.

Tags

HashtagMetagenomi

Company: Metagenomi
close
Search CRISPR Medicine